Chest Shielding in Premature Infants During Phototherapy
NCT ID: NCT02552927
Last Updated: 2020-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2015-08-01
2019-02-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Phototherapy in Preterm Infants Pda
NCT03675425
Cycled Phototherapy
NCT03927833
Consequences of Parenteral Nutrition Photoprotection on Oxidant Related Diseases Among Extremely Low Birth Weight Infants
NCT00328419
Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
NCT03026192
Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates
NCT01434810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CALF
Chest shield with aluminum foil
Chest shield with aluminum foil (CALF)
SHIELD
Chest shield without aluminum foil
SHIELD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chest shield with aluminum foil (CALF)
SHIELD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the NICU (Neonatal intensive care unit) within 24 hours after birth
* English speaking parents
Exclusion Criteria
* Chromosomal disorders
* Cyanotic heart defects
* Nitric oxide
* Prophylactic phototherapy
* Unlikely to survive beyond 72 hours according to the attending neonatologist
* Do not require phototherapy
23 Weeks
33 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Javed Mannan, MD, MPH
Role: STUDY_DIRECTOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mannan J, Amin SB. Effect of chest shielding during phototherapy for hyperbilirubinemia on symptomatic patent ductus arteriosus - a double-blind randomized placebo-controlled trial. Pediatr Res. 2024 Dec;96(7):1771-1776. doi: 10.1038/s41390-024-03310-4. Epub 2024 Jun 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
911
Identifier Type: OTHER
Identifier Source: secondary_id
55472
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.